BuzzSparks.org

ARCH Venture Partners


ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences, physical sciences, and information technology. They enjoy special recognition as a leader in...

Founded in 1986
Homepage:

ARCH Midwest

60631 8725 W. Higgins Road, Suite 290

Chicago
USA IL

Phone: 773 380 6600

Updated on Jun 3, 2009
ARCH Venture Partners at CrunchBase
Frederic Veyssiere Co-Founder and Managing Partner
Steven Lazarus Co-founder and Managing Director
Robert T. Nelsen Co-founder and Managing Director
Clinton W. Bybee Co-Founder and Managing Director
David Cruikshank Vice President
Keith L. Crandell Co - Founder & Managing Director
Paul Thurk Managing Director
Alex Rives Affiliate
Ken Bradley Venture Partner
Hong Hou Venture Partner
Michael Knapp Venture Partner
Cindy Bayley Affiliate
Bob Nelsen Managing Director
Steven Gillis Managing Director
Kristina Burrow Managing Director
Nathaniel David Venture Partner
Edgar Hotard Venture Partner
George Kadifa Venture Partner
Nicholas Darby Executive in Residence
Dan Crowley Affiliate
Past
Mark McDonnell Managing Director, CFO and CAO
Daniel Leff Co-Investors
Scott Minick Managing Director
Brooks Herman Intern
Joseph Jeong Analyst

October, 2013

ARCH Venture Partners invested $18M in Boreal Genomics as a Series C round

August, 2013

ARCH Venture Partners invested $7M in 908 Devices as a Series B round

April, 2013

ARCH Venture Partners invested $30M in Syros Pharmaceuticals as a Series A round

ARCH Venture Partners invested $14.5M in AgBiome as a Series A round

March, 2013

ARCH Venture Partners invested $8M in Theraclone Sciences as a Series B round

November, 2012

ARCH Venture Partners invested $18.5M in Quanterix as a Series C round

September, 2012

ARCH Venture Partners invested $8.1M in 908 Devices as a Series A round

July, 2012

ARCH Venture Partners invested $30M in Siluria Technologies as a Series C round

ARCH Venture Partners invested $21M in Impinj as unattributed round

ARCH Venture Partners invested $60M in bluebird bio as a Series D round

ARCH Venture Partners invested $38.5M in Chiasma as a Series D round

March, 2012

ARCH Venture Partners invested $30M in Receptos as unattributed round

January, 2012

ARCH Venture Partners invested $7.5M in Semprius as unattributed round

December, 2011

ARCH Venture Partners invested $6M in Groove Biopharma as a Series B round

November, 2011

ARCH Venture Partners invested $78M in Agios Pharmaceuticals as a Series C round

September, 2011

ARCH Venture Partners invested $20M in Siluria Technologies as a Series B round

ARCH Venture Partners invested $37.4M in Kythera Biopharmaceuticals as a Series D round

August, 2011

ARCH Venture Partners invested $15.2M in Shocking Technologies as a Series C round

ARCH Venture Partners invested $14M in Pulmatrix as a Series B round

ARCH Venture Partners invested $2.1M in Oncofactor Corporation as a Series A round

June, 2011

ARCH Venture Partners invested $20M in Semprius as a Series C round

ARCH Venture Partners invested $36M in Sorbent Therapeutics as a Series B round

April, 2011

ARCH Venture Partners invested $30M in bluebird bio as unattributed round

January, 2011

ARCH Venture Partners invested $7M in Univa as unattributed round

ARCH Venture Partners invested $4.4M in Acylin Therapeutics as a Series A round

October, 2010

ARCH Venture Partners invested unknown amount in Kilimanjaro Energy as a Series A round

ARCH Venture Partners invested $13.3M in Siluria Technologies as unattributed round

September, 2010

ARCH Venture Partners invested $21.8M in Sorbent Therapeutics as a Series B round

August, 2010

ARCH Venture Partners invested $4M in Crystal IS as a Series B round

ARCH Venture Partners invested $5M in Ciespace as a Series A round

June, 2010

ARCH Venture Partners invested $12.4M in Bind Biosciences as a Series C round

ARCH Venture Partners invested $3.5M in Adesto Technologies as unattributed round

April, 2010

ARCH Venture Partners invested $3.9M in Mirina as a Series A round

ARCH Venture Partners invested $56M in Achaogen as a Series C round

March, 2010

ARCH Venture Partners invested $1.5M in Theraclone Sciences as unattributed round

February, 2010

ARCH Venture Partners invested $8M in Shocking Technologies as a Series B round

January, 2010

ARCH Venture Partners invested $51.6M in VentiRx Pharmaceuticals as a Series A round

ARCH Venture Partners invested $18M in Innovalight as a Series D round

November, 2009

ARCH Venture Partners invested $25M in Receptos as a Series A round

ARCH Venture Partners invested $30M in Fate Therapeutics as a Series B round

ARCH Venture Partners invested $30.2M in Pulmatrix as a Series B round

ARCH Venture Partners invested $14.5M in Cambrios Technologies as a Series D round

October, 2009

ARCH Venture Partners invested $15M in Innovalight as unattributed round

August, 2009

ARCH Venture Partners invested $10M in Shocking Technologies as a Series B round

July, 2009

ARCH Venture Partners invested $15M in Limerick BioPharma as a Series C round

June, 2009

ARCH Venture Partners invested $6.4M in Semprius as a Series B round

May, 2009

ARCH Venture Partners invested $12M in Elixir Pharmaceuticals as a Series D round

ARCH Venture Partners invested $36M in Lycera as a Series A round

January, 2009

ARCH Venture Partners invested $7M in Qwell Pharmaceuticals as a Series A round

September, 2008

ARCH Venture Partners invested $35M in Sapphire Energy as a Series D round

June, 2008

ARCH Venture Partners invested $15.2M in Limerick BioPharma as unattributed round

May, 2008

ARCH Venture Partners invested $50M in Sapphire Energy as a Series C round

ARCH Venture Partners invested $30M in Kythera Biopharmaceuticals as a Series C round

ARCH Venture Partners invested $8M in Univa UD as a Series B round

February, 2008

ARCH Venture Partners invested $19M in PhaseRx as a Series A round

ARCH Venture Partners invested $10M in KOTURA as a Series C round

ARCH Venture Partners invested $7M in MediaPhy as unattributed round

November, 2007

ARCH Venture Partners invested $12M in Fate Therapeutics as a Series A round

October, 2007

ARCH Venture Partners invested $30M in Allozyne as a Series B round

August, 2007

ARCH Venture Partners invested $52M in Xtera Communications as unattributed round

July, 2007

ARCH Venture Partners invested $4.1M in Semprius as a Series A round

April, 2007

ARCH Venture Partners invested $7M in Shocking Technologies as a Series A round

March, 2007

ARCH Venture Partners invested $19M in Impinj as a Series E round

February, 2007

ARCH Venture Partners invested $63M in Omeros as a Series E round

November, 2006

ARCH Venture Partners invested $46M in Elixir Pharmaceuticals as a Series C round

ARCH Venture Partners invested $44M in Chiasma as a Series C round

October, 2006

ARCH Venture Partners invested $6.3M in Aveso as a Series B round

ARCH Venture Partners invested $26M in Achaogen as a Series B round

August, 2006

ARCH Venture Partners invested $10.6M in Crystal IS as a Series B round

July, 2006

ARCH Venture Partners invested $30M in Kythera Biopharmaceuticals as a Series B round

ARCH Venture Partners invested $25M in AmberWave as a Series E round

June, 2006

ARCH Venture Partners invested $21.8M in Nitronex as unattributed round

ARCH Venture Partners invested $55M in VLST Corporation as a Series B round

December, 2005

ARCH Venture Partners invested $26.5M in Impinj as unattributed round

ARCH Venture Partners invested $3.5M in Allozyne as a Series A round

November, 2005

ARCH Venture Partners invested $41.5M in nanosys as a Series D round

September, 2005

ARCH Venture Partners invested $13M in KOTURA as a Series B round

August, 2005

ARCH Venture Partners invested $8M in Univa UD as a Series A round

February, 2005

ARCH Venture Partners invested $12M in Cambrios Technologies as a Series B round

January, 2005

ARCH Venture Partners invested $10M in Ahura Scientific as a Series B round

May, 2004

ARCH Venture Partners invested $15M in Ensemble Discovery as a Series A round

1986

ARCH Venture Partners was founded in 1986